Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 1

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02436538Completed

Correlation Between Serum Anti-Müllerian Hormone & Müllerian Ducts Anomalies in Infertility

Role: collaborator

NCT02325479Phase 1Completed

Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI)

Role: lead

NCT01529177Phase 4Unknown

Metformin for the Treatment of Unexplained Oligozspermia

Role: lead

NCT01509482Not ApplicableCompleted

Insulin Resistance in Idiopathic Oligospermia and Azoospermia

Role: lead

NCT01064219Not ApplicableCompleted

Intrauterine Human Chorionic Gonadotrophins (hCG) and Endometrial Treg Cells

Role: lead

NCT01030393Phase 4Completed

Intra-uterine Injection of Human Chorionic Gonadotrophin (hCG) Before Embryo Transfer

Role: lead

NCT01032642Not ApplicableCompleted

A Thin Catheter For Hystrosalpingography

Role: collaborator

All 7 trials loaded